Pinnaduwage Dilini S, Cunha J Adam, Weinberg Vivian, Krishnamurthy Devan, Nash Marc, Hsu I-Chow, Pouliot Jean
Department of Radiation Oncology, University of California San Francisco, San Francisco, CA.
Brachytherapy. 2013 Sep-Oct;12(5):487-94. doi: 10.1016/j.brachy.2013.02.003. Epub 2013 Apr 11.
To evaluate the dosimetric impact of using one treatment plan for multiple fractions from a single tandem and ring applicator insertion of high-dose-rate brachytherapy for cervical cancer.
Thirteen cervical cancer patients undergoing high-dose-rate brachytherapy were followed. Patients received the total dose from a single applicator insertion in two fractions, given with at least 6 hours apart within 24 hours. The treatment plan was based on a CT scan taken before the first treatment fraction. A second CT was obtained before the second treatment fraction. The co-registered image series were used to evaluate the dosimetric impact of using a single treatment plan for both fractions. Applicator and catheters were measured to quantify interfraction displacement.
When the Day 1 plan was applied to the Day 2 images, high-risk clinical target volume (HR-CTV) coverage was reduced by as much as 17.4 percentage points. The mean decrease was 9.4 ± 5.0 percentage points (p < 0.0001). The rectum V75 increase was significant (p = 0.03), whereas the bladder V75 increase was not significant (p = 0.28). Volume changes in the HR-CTV contour from Day 1 to Day 2 were also observed (p = 0.29). Maximum applicator and catheter displacements of 10-30mm were seen, from Day 1 to Day 2.
When the Day 1 plan was used on the Day 2, the HR-CTV coverage decreased significantly (p < 0.0001). Our study establishes the need for institutions to evaluate the necessity for replanning based on imaging obtained before each treatment fraction for their gynecologic brachytherapy techniques.
评估针对宫颈癌高剂量率近距离放射治疗单次串联和环形施源器插入的多个分次使用单一治疗计划的剂量学影响。
对13例接受高剂量率近距离放射治疗的宫颈癌患者进行随访。患者在单次施源器插入后分两次接受总剂量,两次给药间隔至少6小时且在24小时内完成。治疗计划基于第一次治疗分次前的CT扫描。在第二次治疗分次前获取第二次CT扫描。通过配准后的图像序列评估对两个分次使用单一治疗计划的剂量学影响。测量施源器和导管以量化分次间位移。
当将第1天的计划应用于第2天的图像时,高危临床靶区(HR-CTV)覆盖率降低多达17.4个百分点。平均降低9.4±5.0个百分点(p<0.0001)。直肠V75增加显著(p=0.03),而膀胱V75增加不显著(p=0.28)。还观察到从第1天到第2天HR-CTV轮廓的体积变化(p=0.29)。从第1天到第2天,施源器和导管的最大位移为10 - 30mm。
当在第2天使用第1天的计划时,HR-CTV覆盖率显著降低(p<0.0001)。我们的研究表明,各机构有必要根据其妇科近距离放射治疗技术在每个治疗分次前获得的影像评估重新计划的必要性。